Trials / Conditions / Prostatic Cancer, Castration-Resistant
Prostatic Cancer, Castration-Resistant
6 registered clinical trials studyying Prostatic Cancer, Castration-Resistant — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Ca NCT07047118 | Novartis Pharmaceuticals | Phase 2 |
| Recruiting | Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastas NCT06276465 | UNICANCER | Phase 3 |
| Completed | Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer NCT04381832 | Arcus Biosciences, Inc. | Phase 1 / Phase 2 |
| Terminated | Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balanc NCT04157088 | Bayer | Phase 2 |
| Unknown | Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer NCT04141709 | Technische Universität Dresden | N/A |
| Withdrawn | Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA) NCT02866916 | Institut Claudius Regaud | Phase 1 |